BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND RBM10, GPATC9, 8241, ENSG00000182872, CTD-2522E6_5, GPATCH9, KIAA0122, P98175, MGC1132, DXS8237E, ZRANB5, MGC997 AND Prognosis
8234 results:

  • 1. prognosis and influencing factors of ER-positive, HER2-low breast cancer patients with residual disease after neoadjuvant chemotherapy: a retrospective study.
    Tang L; Jiang L; Shu X; Jin Y; Yu H; Liu S
    Sci Rep; 2024 May; 14(1):11761. PubMed ID: 38783028
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [The effect of ubiquitin ligase Cullin3 on the proliferation, migration and invasion of triple-negative breast cancer cells and exploration of its mechanism].
    He ZX; Li J; Wang QF; Cheng Q; Ni SJ
    Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1868-1878. PubMed ID: 38782756
    [No Abstract]    [Full Text] [Related]  

  • 3. [The pathological characteristics and prognostic analysis of medullary thyroid microcarcinoma].
    Li DP; Zhang JM; Zhang YH; Hu LF; Gao Y; Wei SF; Zheng XQ
    Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1825-1830. PubMed ID: 38782750
    [No Abstract]    [Full Text] [Related]  

  • 4. circ_0000592 facilitates the progression of esophageal squamous cell carcinoma via miR-155-5p/FZD5 axis.
    He J; Yu K; Liang G; Shen W; Tian H
    J Biochem Mol Toxicol; 2024 Jun; 38(6):e23742. PubMed ID: 38780005
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prevention of persistent pain with lidocaine infusions in breast cancer surgery (PLAN): study protocol for a multicenter randomized controlled trial.
    Khan JS; Gilron I; Devereaux PJ; Clarke H; Ayach N; Tomlinson G; Quan ML; Ladha KS; Choi S; Munro A; Brull R; Lim DW; Avramescu S; Richebé P; Hodgson N; Paul J; McIsaac DI; Derzi S; Zbitnew GL; Easson AM; Siddiqui NT; Miles SJ; Karkouti K;
    Trials; 2024 May; 25(1):337. PubMed ID: 38773653
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinicopathological features, prognostic factor analysis, and survival nomogram of patients with double primary cancers involving lung cancer.
    Hao Y; Zhang X; Cui G; Qi X; Jiang Z; Yu L
    Cancer Med; 2024 May; 13(10):e7296. PubMed ID: 38770671
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Retrospective analysis of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor-2 (HER2), Ki67 changes and their clinical significance between primary breast cancer and metastatic tumors.
    Qi G; Zhang X; Gai X; Yan X
    PeerJ; 2024; 12():e17377. PubMed ID: 38766488
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The prognostic value of preoperative neoindices consisting of lymphocytes, neutrophils and albumin (LANR) in operable breast cancer: a retrospective study.
    Wang Y; Zhuang J; Wang S; Wu Y; Chen L
    PeerJ; 2024; 12():e17382. PubMed ID: 38766483
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Patterns of distant metastasis and survival outcomes in
    Liu K; Huang AL; Chen XQ; Wu SG
    Front Endocrinol (Lausanne); 2024; 15():1385756. PubMed ID: 38752173
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Clinicopathologic features and genomic profiling of female axillary lymph node metastases from adenocarcinoma or poorly differentiated carcinoma of unknown primary.
    Tang L; Zhu Y; Du Y; Long X; Long Y; Tang Y; Liu J
    J Cancer Res Clin Oncol; 2024 May; 150(5):256. PubMed ID: 38750402
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. DNA methylation regulator-based molecular subtyping and tumor microenvironment characterization in hepatocellular carcinoma.
    Zhao J; Liu Z; Yang K; Shen S; Peng J
    Front Immunol; 2024; 15():1333923. PubMed ID: 38736884
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Transcript and protein signatures derived from shared molecular interactions across cancers are associated with mortality.
    Zhao Y; Li X; Loscalzo J; Smelik M; Sysoev O; Wang Y; Mahmud AKMF; Mansour Aly D; Benson M
    J Transl Med; 2024 May; 22(1):444. PubMed ID: 38734658
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A Competing Risk Nomogram for Prediction of prognosis in Patients With Primary Squamous Cell Thyroid Carcinoma.
    Tian Y; He L; Zhang B; Deng L; Wang J
    Technol Cancer Res Treat; 2024; 23():15330338241254059. PubMed ID: 38725285
    [No Abstract]    [Full Text] [Related]  

  • 14. Identification of breast cancer Subtypes Based on Endoplasmic Reticulum Stress-Related Genes and Analysis of prognosis and Immune Microenvironment in breast cancer Patients.
    Yi C; Yang J; Zhang T; Qin L; Chen D
    Technol Cancer Res Treat; 2024; 23():15330338241241484. PubMed ID: 38725284
    [No Abstract]    [Full Text] [Related]  

  • 15. Time Kinetics and prognosis roles of calcitonin after surgery for medullary thyroid carcinoma.
    Guo F; Fu G; Li F; Hua Y; Wang Z; Zheng X; Zhao J; Gao M
    World J Surg Oncol; 2024 May; 22(1):121. PubMed ID: 38711029
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. T-reg transcriptomic signatures identify response to check-point inhibitors.
    Noblejas-López MDM; García-Gil E; Pérez-Segura P; Pandiella A; Győrffy B; Ocaña A
    Sci Rep; 2024 May; 14(1):10396. PubMed ID: 38710724
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Effect of young age (below 40 years) on oncologic outcomes in Lebanese patients with breast cancer: a matched cohort study.
    Sbaity E; Tamim H; El-Hajj Fuleihan G; Abbas J; Zahwe M; El Sayed R; Shamseddine A
    BMC Cancer; 2024 May; 24(1):560. PubMed ID: 38704543
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A novel long non-coding RNA MIR4500HG003 promotes tumor metastasis through miR-483-3p-MMP9 axis in triple-negative breast cancer.
    Lin WD; Chang CH; Pan JK; Lin FC; Chen YC; Chen YJ; Wang PS; Hong WQ; Chen SY; Lin CH; Kuo YL; Chung WP; Cheng HC; Hsiao M; Yang CN; Lu PJ
    Cell Death Dis; 2024 May; 15(5):310. PubMed ID: 38697967
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Additional prognostic value of polymorphisms within the 3'-untranslated region of programmed cell death pathway genes in early-stage breast cancer.
    Chen H; Chen M; Zeng B; Tang L; Nie Q; Jin X; Guo W; Chen L; Lin Y; Wang C; Fu F
    Front Immunol; 2024; 15():1284579. PubMed ID: 38690279
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Evaluating Recurrence Risk in Patients Undergoing breast-conserving Surgery Using E-cadherin Staining as a Biomarker.
    Kao CN; Chen CC; Chu WL; Luo CW; Huang WL; Moi SH; Hou MF; Pan MR
    In Vivo; 2024; 38(3):1143-1151. PubMed ID: 38688621
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 412.